Increased Plasma Heparanase Activity in COVID-19 Patients
Baranca Buijsers(Radboud University Nijmegen), Johan van der Vlag(Radboud University Nijmegen), Marissa L. Maciej-Hulme(Radboud University Nijmegen), Luuk B. Hilbrands(Radboud University Nijmegen), Tom Nijenhuis(Radboud University Nijmegen), Peter Pickkers(Radboud University Nijmegen), Nico Janssen(Radboud University Nijmegen), Mihai G. Netea(Radboud University Nijmegen), Quirijn de Mast(Radboud University Nijmegen), Leo A. B. Joosten(Radboud University Nijmegen), Raphaël Duivenvoorden(Radboud University Nijmegen), Matthijs Kox(Radboud University Medical Center), Mark de Graaf(Radboud University Nijmegen), Aline de Nooijer(Roosevelt Institute for American Studies), Frank L. van de Veerdonk(Radboud University Nijmegen), Inge Jonkman(Radboud University Nijmegen), Inge Grondman(Radboud University Nijmegen), Nils Rother(Radboud University Nijmegen), Cansu Yanginlar(Radboud University Nijmegen)
Cited by 136
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k